Randa Abdelmasih, MD
NPI 1003377417ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Galveston, TX
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) with Utmb Faculty Group Practice, practicing in Galveston, Texas. Their prescriptions cost Medicare Part D more than their services did: $344,407 for 704 claims, against $7,360 paid for services in 2024. Lilly USA, LLC was the largest of 17 companies reporting payments in 2025, $1,293 in all, mostly food and beverage. Lists University of Texas Medical Branch Galveston as a hospital affiliation.
Overview
| NPI | 1003377417 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Mar 28, 2019 |
| Last updated in NPPES | Jun 13, 2024 |
| Certified by provider | Jun 13, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | U5621 | TX |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 71 |
|---|---|
| Services billed | 130 across 8 procedure codes |
| Paid by Medicare | $7,360 |
Part D prescriptions in 2024
| Prescriptions (claims) | 704 · 1,452 30-day fills |
|---|---|
| Patients | 166 |
| Total drug cost | $344,407 |
| Generic share | 36% of claims |
Education and affiliations
| Graduation year | 2015 |
|---|---|
| Medicare specialty | Endocrinology |
Medical group
- Utmb Faculty Group PracticeGalveston, TX · 1,101 clinicians
Hospital affiliation
- University of Texas Medical Branch GalvestonGalveston, TX
Industry payments (Open Payments)
- 2025$1,293 · 47 payments from 17 companies
- 2024$900.11 · 28 payments from 13 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Lilly USA, LLC | $178.22 | 4 |
| Ascendis Pharma Endocrinology Inc | $151.52 | 2 |
| Corcept Therapeutics | $146.04 | 8 |
| Neurocrine Biosciences, Inc. | $133.79 | 3 |
| Madrigal Pharmaceuticals | $118.25 | 4 |
What the 2025 payments were for
- Food and Beverage$1,293 · 47 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Galveston
- 1780875963
- 1568521375
- 1487752804
- 1033278833
- 1982622148
- 1255658340
- 1679197461
- 1487713996
- 1770642126
- 1073928016
- 1043877954
- 1053963389
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →